|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 309.00 BDT | +6.11% |
|
+7.03% | -9.57% |
| Market Cap | 6.37B 51.72M 45.22M 41.71M 38.34M 72.65M 4.98B 73.89M 498M 195M 2.43B 194M 190M 8.38B | P/E 2024 |
231x | P/E 2025 | 182x |
|---|---|---|---|---|---|
| Enterprise Value | 6.67B 54.17M 47.36M 43.69M 40.16M 76.1M 5.21B 77.4M 522M 205M 2.55B 203M 199M 8.78B | EV / Sales 2024 |
12.2x | EV / Sales 2025 | 10.1x |
| Free-Float |
59.39% | Yield 2024 |
0.25% | Yield 2025 | 0.64% |
| 1 day | +6.11% | ||
| 1 week | +7.03% | ||
| Current month | -1.28% | ||
| 1 month | -2.92% | ||
| 3 months | -7.04% | ||
| 6 months | -12.96% | ||
| Current year | -9.57% |
| 1 week | 290.5 | 312 | |
| 1 month | 285 | 325 | |
| Current year | 285 | 391.8 | |
| 1 year | 285 | 587.5 | |
| 3 years | 217.2 | 726.9 | |
| 5 years | 69.5 | 1,000 | |
| 10 years | 44 | 1,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 45 | 2013-12-31 | |
| Director of Finance/CFO | - | 2020-11-07 | |
| Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 71 | 2013-12-31 | |
Arzuda Karim
BRD | Director/Board Member | 71 | 1983-05-04 |
| Director/Board Member | 45 | 1999-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.11% | +7.03% | -8.58% | -11.23% | 48.08M | ||
| +0.26% | -5.19% | +49.36% | +157.79% | 1,028B | ||
| -2.17% | -5.72% | +60.04% | +56.12% | 611B | ||
| +1.59% | -2.50% | +32.21% | +82.76% | 432B | ||
| +0.98% | -1.40% | +29.49% | +23.12% | 323B | ||
| -0.34% | -3.10% | +27.00% | +43.66% | 277B | ||
| +1.63% | -11.76% | +19.72% | +23.20% | 257B | ||
| +3.39% | +2.29% | -23.68% | -38.33% | 217B | ||
| +0.95% | -2.60% | +22.54% | +57.32% | 192B | ||
| +1.44% | -2.82% | +21.03% | +70.36% | 161B | ||
| Average | +1.43% | -4.33% | +22.91% | +46.48% | 349.84B | |
| Weighted average by Cap. | +0.45% | -5.52% | +36.02% | +77.71% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 827M 6.71M 5.87M 5.42M 4.98M 9.43M 646M 9.59M 64.66M 25.37M 316M 25.22M 24.66M 1.09B | 665M 5.4M 4.72M 4.35M 4M 7.58M 519M 7.71M 51.96M 20.39M 254M 20.26M 19.82M 875M |
| Net income | 42.33M 344K 300K 277K 255K 483K 33.06M 491K 3.31M 1.3M 16.16M 1.29M 1.26M 55.69M | 35.02M 284K 249K 229K 211K 399K 27.35M 406K 2.74M 1.07M 13.37M 1.07M 1.04M 46.08M |
| Net Debt | 290M 2.36M 2.06M 1.9M 1.75M 3.31M 227M 3.37M 22.7M 8.91M 111M 8.85M 8.66M 382M | 302M 2.45M 2.14M 1.98M 1.82M 3.44M 236M 3.5M 23.61M 9.26M 115M 9.21M 9.01M 397M |
Employees
563
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | BDT 309.00 | +6.11% | 544,308 |
| 26-07-14 | BDT 291.20 | +0.10% | 120,581 |
| 26-07-13 | BDT 290.90 | -1.56% | 155,067 |
| 26-07-12 | BDT 295.50 | -0.71% | 170,531 |
| 26-07-09 | BDT 297.60 | +2.55% | 211,915 |
- Stock Market
- Stocks
- ORIONINFU Stock
Select your edition
All financial news and data tailored to specific country editions
















